A path plagued by progression: The chronic kidney disease journey
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
As therapies become increasingly complex and personalized, it is imperative that physicians...
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
As life settles into the new normal after the worst of the COVID-19 pandemic, it is clear that...
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
A recent survey by the Deloitte Center for Health Solutions of biopharma executives and other...
Diabetes is a complex disease that affects over 37 million Americans, or 11% of the population, and...
Written by Emery Niemiec, Director, Partners & Alliance at HealthVerity I had the pleasure of...
The Inside Story Behind MOM, the Maternal Outcomes Masterset In the Spring of 2021, HealthVerity...
Written by Emery Niemiec I recently attended the 2022 INFORMS Business Analytics Conference and had...
This is part one of a three-part series on the essential qualities of claims data for life sciences research. Next up: the role of consistent data in producing reliable and reproducible results.